Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs V.TAK


Primary Symbol: TAK

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.


NYSE:TAK - Post by User

Comment by rory17on Apr 07, 2013 11:58am
91 Views
Post# 21222826

RE: RE: Krutec

RE: RE: Krutec

Your points are well made. I do disagree that ATC and KAM's upside is limited. The share prices are very cheap in comparison to their highs of 2 years ago just like TAK's. is now. But both these companies have real and substantial drill results and more than enough capital to complete this summer's drilling programs and beyond. Agnico Eagle just put 13 million into ATC a few weeks back. TAK has very limited funds and management continues to pay themselves regardless, and they has lost the confidence of their institutional investors. TAK managemnet stated they will be out of money in 6 months in the last Sedar filing. I hope you are right and good luck to you. 

Bullboard Posts